Procept BioRobotics is a surgical robotics company that has its headquarters in San Jose, California. The company’s mission is to improve patient care by developing cutting-edge solutions in the field of urology. Recently, members of management from the company announced that they would be presenting at the 44th Annual TD Cowen Health Care Conference in Boston. The presentation will take place on Tuesday, March 5 at 12:50 p.m. Eastern Time and can be accessed via a live webcast or an archived recording on the “Investors” section of their website for at least 90 days after the event.
Procept BioRobotics’ primary focus is on creating, manufacturing, and selling their AquaBeam Robotic System, which is an advanced, image-guided surgical robotic system designed for use in minimally invasive urologic surgery. Initially, this system will be used to treat benign prostatic hyperplasia (BPH), a common prostate disease affecting approximately 40 million men in the United States. The company aims to provide effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms (LUTS) due to BPH, regardless of prostate size and shape or surgeon experience.
Throughout its development process, Procept BioRobotics has built up a substantial body of clinical evidence to support the benefits and clinical advantages of Aquablation therapy. This includes nine clinical studies and over 150 peer-reviewed publications.
Interested viewers can learn more about this innovative system and the company’s advancements in urology by attending a live webcast or an archived recording of the presentation available for at least 90 days after the event on the “Investors” section of their website.